A previous post reported on a declaratory judgment action brought by DuPont-owned biopharmaceutical company Danisco against Novozymes. The two companies are both Danish and appear to be arch rivals. As the court described it, they are “reputedly the two major competitors in the field of developing and supplying industrial enzymes used in (more…)

In previous posts I discussed the patent infringement suit brought by Danish biotech Novozymes against its rival Danisco (recently acquired by DuPont).

Specifically, Novozymes sued Danisco in May 2010 in the Western District of Wisconsin, alleging infringement of U.S. Patent No. 7,713,723 (’723 (more…)

In a previous post, I wrote about a patent infringement suit between Danish biopharm rivals Novozymes and Danisco, which are both active in developing enzymes used in production of biofuels.

In the suit, Novozymes has accused Danisco of infringing U.S. Patent No. 7,713,723 (’723 Patent) by selling alpha amylase enzymes (more…)